A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System

Gemcitabine is an antineoplastic drug used in several forms of advanced pancreatic, lung, breast, ovarian, and bladder cancer. Common side effects include bone marrow suppression, fatigue, diarrhea, nausea, gastrointestinal upset, rash, alopecia, and stomatitis. Transient serum enzyme elevations cou...

Full description

Saved in:
Bibliographic Details
Main Authors: Ilenia Mascherona, Caterina Maggioli, Maira Biggiogero, Oreste Mora, Lucia Marelli
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Hepatology
Online Access:http://dx.doi.org/10.1155/2020/8812983
Tags: Add Tag
No Tags, Be the first to tag this record!